Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China
· Delayed Price · Currency is CNY 30.80
+0.01 (0.03%)
At close: Apr 29, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 11.29 billion as of April 29, 2026. Its market cap has increased by 10.91% in one year.
Market Cap
11.29B
Enterprise Value
10.02B
Revenue
230.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.80
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 11.29B, a decrease of -9.47%. That is a compound annual growth rate of -3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.29B | 13.03% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 11.55B |
| Hualan Biological Vaccine | 11.18B |
| Pacific Shuanglin Bio-pharmacy | 11.93B |
| Chengdu Easton Biopharmaceuticals | 11.10B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.93B |
| Vcanbio Cell & Gene Engineering Corp., | 12.35B |
| HitGen | 10.49B |
| InventisBio | 12.89B |